Grants and funding for social organisations

Resolución de 10 de junio de 2026, de la Presidencia del ICECYL que aprueba la convocatoria de subvenciones para financiar proyectos de I+D en ámbitos de tecnologías fundamentales incluidos en el programa del Fondo de Transición Justa de España

AUTONOMICA - CASTILLA Y LEÓN - INSTITUTO PARA LA COMPETITIVIDAD EMPRESARIAL DE CASTILLA Y LEÓN ·

Who can apply GRAN EMPRESA; PYME Y PERSONAS FÍSICAS QUE DESARROLLAN ACTIVIDAD ECONÓMICA

Investigación, desarrollo e innovación

Period: Jun 16, 2026 – —

(DIN) Commercial Revitalization Actions (Reg. Mímimis 2023/2831)

AUTONOMICA - LA RIOJA - AGENCIA DE DESARROLLO ECONÓMICO DE LA RIOJA ·

Trade, Tourism and SMEs

Sostegno ai Progetti di R&S delle MPMI nella Piattaforma Energie Rinnovabili - Sardegna Ricerche

Sardegna Ricerche · Sardegna

Who can apply Impresa

Cos'è Il presente avviso, pubblicato nell’ambito dell’Azione 1.1.1, Priorità 1, del Programma Regionale Sardegna FESR 2021-2027, si riferisce alla presentazione di progetti di ricerca e sviluppo nell’ambito dell’area di specializzazione “Reti Intelligenti per la gestione efficiente dell’energia” della Strategia di specializzazione intelligente regionale (S3), con particolare riferimento alle tecnologie per la transizione energetica. L’intervento mira a rafforzare l’ecosistema regionale della ricerca sostenendo la propensione delle imprese del territorio ad investire in attività di ricerca industriale e sviluppo sperimentale, anche in collaborazione con il sistema della ricerca. L’intervento è finalizzato ad incrementare la collaborazione tra le imprese regionali e la Piattaforma Energie rinnovabili di Sardegna Ricerche e a sostenere progetti da svolgere all’interno della Piattaforma. A chi si rivolge Il bando è rivolto a Micro, Piccole e Medie Imprese (MPMI), così come definite dall’Allegato I del Reg. (UE) n. 651/2014, in forma singola o aggregata con un unico Organismo di Ricerca che, alla data di presentazione della domanda, siano in possesso dei requisiti stabiliti all’art.3 delle Disposizioni attuative del bando. Cosa prevede Vengono supportati i progetti di ricerca e sviluppo realizzati in Sardegna nell’area di specializzazione “Reti Intelligenti per la gestione efficiente dell’energia” della S3 regionale, con particolare riferimento alle tecnologie per la transizione energetica. Il bando prevede una sovvenzione a fondo perduto sui costi ammissibili del progetto di ricerca e sviluppo approvato.

Period: Mar 16, 2026 – —

Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)

United States · US

Who can apply Native American tribal organizations (other than Federally recognized tribal governments) · Private institutions of higher education · Independent school districts · City or township governments · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Small businesses · Special district governments · County governments · Others (see text field entitled "Additional Information on Eligibility" for clarification) · For profit organizations other than small businesses · Native American tribal governments (Federally recognized) · State governments · Public and State controlled institutions of higher education · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Public housing authorities/Indian housing authorities

This Notice of Funding Opportunity (NOFO) announces the restructured Shared Instrumentation Grant (SIG) Program that consolidates three existing shared-use instrumentation programs, i.e., the Shared Instrumentation Grant program, the High-End Instrumentation Grant program, and the Basic Instrumentation Grant program. The NOFO invites applications from groups of NIH-supported investigators to purchase or upgrade a single state-of-the-art commercially available instrument or an integrated instrumentation system. The instruments purchased through the SIG Program are required to be optimally shared among the users to ensure efficient and cost-effective research operations, enable rigorous and reproducible measurements, and encourage collaborative research and benefit broad research communities at large. The minimum award is $300,000. There is no cap on the total cost of the instrument; however, the maximum award is $5,000,000. Cost sharing is required for premium instruments or special use instruments.

Seed Instrumentation Support (SIS) Program (S10 Clinical Trial Not Allowed)

United States · US

Who can apply Special district governments · Native American tribal governments (Federally recognized) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Public housing authorities/Indian housing authorities · Private institutions of higher education · For profit organizations other than small businesses · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Public and State controlled institutions of higher education · Independent school districts · Small businesses · County governments · City or township governments · State governments · Native American tribal organizations (other than Federally recognized tribal governments)

This Notice of Funding Opportunity (NOFO) aims to build new research capacity and develop a sustainable research program by supporting the purchase of a single commercially available biomedical research instrument currently unavailable in the institution. Instruments funded through this program must be shared among the users to create new research opportunities, enable reproducible data generation, encourage collaborative research and training, and strengthen long-term research capabilities. The minimum award is $50,000. While there is no limit on the total cost of the instrument, the maximum award is $400,000.

INSTRUMENTAL CALL FOR INTERNATIONAL COOPERATION GRANT. 2026 Argentina Heritage. Creation of the Rosario Democratic Memory Network and the dissemination program for its documentary collections in Rosario

ESTADO - MINISTERIO DE ASUNTOS EXTERIORES, UNIÓN EUROPEA Y COOPERACIÓN - AGENCIA ESTATAL AGENCIA ESPAÑOLA DE COOPERACIÓN INTERNACIONAL PARA EL DESARROLLO ·

Who can apply PERSONAS JURÍDICAS QUE NO DESARROLLAN ACTIVIDAD ECONÓMICA

International cooperation for development and culture

Period: Jul 3, 2026 – —

Lasker Clinical Research Scholar's Program (Si2/R00 Clinical Trial Optional)

United States · US

Who can apply Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · City or township governments · Private institutions of higher education · County governments · Native American tribal governments (Federally recognized) · Small businesses · Native American tribal organizations (other than Federally recognized tribal governments) · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Special district governments · Independent school districts · Public housing authorities/Indian housing authorities · For profit organizations other than small businesses · State governments · Public and State controlled institutions of higher education

This NOFO encourages applications for the Lasker Clinical Research Scholars Program. The program supports the research activities of clinical researchers during the early stages of their independent careers as they work to improve human health. The program offers the opportunity for a unique bridge between the NIH intramural and extramural research communities and contains two phases. In the first phase, Lasker Scholars will receive appointments for up to 5-7 years as tenure-track investigators within the NIH Intramural Research Program with independent research budgets. In the second phase, successful scholars will receive up to 3 years of NIH support for their research at an extramural research institute, or can remain as an investigator within the intramural program.

Native American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial Not Allowed)

United States · US

Who can apply Native American tribal governments (Federally recognized) · Native American tribal organizations (other than Federally recognized tribal governments)

The purpose of the Native American Research Centers for Health (NARCH) Planning Grants program is to support federally recognized American Indian/Alaska Native (AI/AN) Tribes, Tribal colleges and universities, Tribal health programs, or Tribal organizations (collectively, eligible AI/AN Tribal entities) to plan and conduct preparatory work for developing competitive NARCH applications.

Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)

United States · US

Who can apply Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Public and State controlled institutions of higher education · Special district governments · County governments · Independent school districts · State governments · City or township governments · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Small businesses · Native American tribal governments (Federally recognized) · Public housing authorities/Indian housing authorities · For profit organizations other than small businesses · Private institutions of higher education

The goal of the Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) program is to provide support for early-career clinician-scientists trained in medical or surgical specialties to launch careers as future leaders in aging- or geriatric-focused research. In support of the program's goal, this GEMSSTAR Notice of Funding Opportunity (NOFO) invites applications that propose to conduct transdisciplinary aging research that will yield pilot data and experience for subsequent aging research projects. The GEMSSTAR program encourages candidates to seek out a supportive research environment to further the program's objectives of fostering the development of early-career clinician-scientists in aging- or geriatric-focused research, particularly as it applies to their clinical specialty/discipline. Toward this end, GEMSSTAR candidates should include a Professional Development Plan that reflects this supportive research environment. In selecting GEMSSTAR recipients, the National Institute on Aging (NIA) will consider the extent to which a candidate's environment is supportive of aging- or geriatric-focused research.

Clinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)

United States · US

Who can apply Small businesses · Public housing authorities/Indian housing authorities · City or township governments · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Native American tribal organizations (other than Federally recognized tribal governments) · Native American tribal governments (Federally recognized) · State governments · Private institutions of higher education · Special district governments · For profit organizations other than small businesses · Independent school districts · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · County governments · Public and State controlled institutions of higher education · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education

This Notice of Funding Opportunity (NOFO) invites researchers to submit applications for support of clinical projects that address critical needs for clinical trial readiness in rare diseases. The initiative seeks applications that are intended to facilitate rare diseases research by enabling efficient and effective movement of candidate therapeutics or diagnostics toward clinical trials, and to increase their likelihood of success. This could be through the development and testing of rigorous biomarkers and clinical outcome assessment measures, or by defining the presentation and course of a rare disease to enable the design of upcoming clinical trials.

BROAD AGENCY ANNOUNCEMENT (BAA) for Extramural Biomedical and Human Performance Research and Development Department of Defense

United States · US

Who can apply Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled "Additional Information on Eligibility"

The FY23 -FY28 Broad Agency Announcement for Extramural Biomedical Research and Development - HT9425-23-S-SOC1.

Defense Security Cooperation University - Research Grants

United States · US

Who can apply Others (see text field entitled "Additional Information on Eligibility" for clarification)

The Defense Security Cooperation Agency’s (DSCA) Defense Security Cooperation University (DSCU) promotes access to and production of knowledge on security cooperation. Security cooperation refers to “all Department of Defense (DoD) interactions with foreign security establishments that build and develop allied and partner security capabilities and capacity for self-defense and multinational operations, provide the Armed Forces of the United States with access to the foreign country during peacetime or a contingency operation, and build relationships that promote specific United States security interests” (Joint Publication 3-20, Security Cooperation, 1-2; see also 10 USC § 16, “Security Cooperation”). Evidence-, theory, and data-building activities that contribute to the body of knowledge on security cooperation or irregular warfare, and that result in lessons that can be applied to practice, are the primary focus of this notice of funding opportunity (NFO). Research products sponsored through this NFO must be unclassified and publicly accessible. DSCU expects awardees to participate in conferences, seminars, focus groups and events, and to make final research products and supporting data (if applicable) easily accessible to the public, in order to enhance dissemination of research findings and facilitate application of lessons learned in areas of policy, practice, and workforce professionalization. The DSCU research grant program, conducted pursuant to 10 USC § 4001 and 10 USC § 384(g), is generally open to a broad range of researchers, although individual DSCU components may have restrictions on who may receive grants. Please see the full NFO for complete details.

Transformative Non-Invasive/Minimally Invasive Technologies for Imaging the Olfactory System Across Scales (R01 CT Optional)

United States · US

Who can apply For profit organizations other than small businesses · Small businesses · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · County governments · Public housing authorities/Indian housing authorities · Special district governments · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Independent school districts · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · City or township governments · Native American tribal organizations (other than Federally recognized tribal governments) · State governments · Public and State controlled institutions of higher education · Native American tribal governments (Federally recognized) · Private institutions of higher education

The National Institute on Deafness and Other Communication Disorders (NIDCD), with the National Institute of Biomedical Imaging and Bioengineering (NIBIB) aims to support the development and/or adaptation of transformative in vivo high-resolution/high specificity imaging of the human olfactory system. Currently, there are limited non-invasive/minimally invasive technologies available for imaging the living human peripheral and central olfactory system with high spatial and temporal resolution. Imaging the olfactory system in the laboratory and in the clinic is essential to understanding underlying biological mechanisms as well as the etiology of an olfactory disorder. Such imaging has proven challenging due to the olfactory system"s unique anatomical and functional characteristics such as restricted accessibility, multiple cell types, and low signal resolution. Addressing these challenges requires multimodal approaches including leveraging existing advanced tools and technologies and developing new tools tailored for the olfactory system. Recent advances in minimally invasive and non-invasive imaging technologies, such as cell specific biomarkers, fluorescence imaging, specialized endoscopes, optical and acoustic imaging, molecular imaging, and hemodynamic and diffusion imaging have the potential to transform our ability to image and investigate the peripheral and central olfactory system in the living human with superior temporal and spatial resolution and eventually improve diagnostic accuracy of olfactory disorders. Applications must leverage advanced non-invasive/minimally invasive imaging technologies to visualize peripheral (e.g., olfactory- and non-olfactory epithelium) and central olfactory (e.g., olfactory bulb) targets at a level previously unattainable. In addition, projects should engage multidisciplinary teams combining expertise in olfaction, biomedical imaging, biochemistry, bioengineering, and biophysics, as appropriate.

Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)

United States · US

Who can apply City or township governments · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · For profit organizations other than small businesses · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · County governments · State governments · Public housing authorities/Indian housing authorities · Small businesses · Independent school districts · Public and State controlled institutions of higher education · Special district governments · Native American tribal governments (Federally recognized) · Private institutions of higher education

The purpose of this Funding Opportunity (NOFO) is to solicit grant applications to support research on the discovery and development of interventions to prevent and/or treat substance use disorders (SUDs) and overdose, including medications and medical devices to treat co-morbid SUDs. This includes preclinical and clinical research studies that will have high impact and quickly yield the necessary results to advance candidate interventions closer to regulatory approval or clinical adoption. This NOFO will utilize the UG3/UH3 activity code.

Stephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)

United States · US

Who can apply Special district governments · Native American tribal governments (Federally recognized) · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Small businesses · Private institutions of higher education · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Public housing authorities/Indian housing authorities · Public and State controlled institutions of higher education · Independent school districts · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · City or township governments · State governments · County governments · For profit organizations other than small businesses · Native American tribal organizations (other than Federally recognized tribal governments)

The Stephen I. Katz Early Stage Investigator Research Project Grant supports an innovative project that represents a change in research direction for an early stage investigator (ESI) and for which no preliminary data exist. Applications submitted to this Notice of Funding Opportunity (NOFO) must not include preliminary data. Applications must include a separate attachment describing the change in research direction.

Support for the creation and development of third places

France · FR

Who can apply Commune · Intercommunalité / Pays · Entreprise publique locale (Sem, Spl, SemOp)

Are you a collective with a third-place project in a New Aquitaine territory where there isn't one yet ? Is your third place already open and you want to develop new activities? This Call for Expressions of Interest (AMI) might be for you! Objectives: - Support the creation of third places in underserved territories, i.e., without an open third place within a 20-minute drive - Consolidate the third-place sector by supporting the development of existing third places, in order to strengthen their territorial roots, professionalize reception conditions, and consolidate their socio-economic models by opening or structuring new service offerings in one of the following 5 areas: Learning and training differently Making and producing differently Nourishing differently Caring differently Experimenting

Period: Apr 1, 2025 – —

Support the creation and development of third places

France · FR

Who can apply Commune · Intercommunalité / Pays · Département · Région

Are you a collective with a third-place project in a territory where there isn't one yet? Is your third place already open and you want to develop new activities? This Call for Expressions of Interest (AMI) might be for you! Objective: Support the creation of third places in underserved territories, i.e., without an open third place within a 20-minute drive. Consolidate the third-place sector by supporting the development of existing third places, in order to strengthen their territorial anchoring, professionalize reception conditions, and consolidate their socio-economic models by opening or structuring new service offerings in one of the following 5 areas: Learning and training differently, Making and producing differently, Nourishing differently, Caring differently, Experimenting.

Vet-LIRN Capacity-Building Project and Equipment Grants (U18)

United States · US

Who can apply Public housing authorities/Indian housing authorities · City or township governments · County governments · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Private institutions of higher education · Public and State controlled institutions of higher education · State governments · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Special district governments · Independent school districts · Small businesses · Native American tribal governments (Federally recognized) · For profit organizations other than small businesses

The goal of this NOFO is to fund veterinary diagnostic laboratories in the Vet-LIRN network for grants associated with projects and equipment. Specific objectives include: 1. Supporting the development, adaptation, or verification/validation of new methods associated with animal food issues or antimicrobial resistance. 2. Short-term surveillance or monitoring efforts aligned with the CVM mission. 3. Supporting equipment for testing or developing tests associated with animal food-related issues or antimicrobial resistance, including those for emerging technologies. 4. Developing projects related to antimicrobial stewardship, in alignment with CVM's key initiatives in this area. 5. Contributing as part of Vet-LIRN's AMR monitoring program, including sequencing isolates. 6. Supporting work associated with One Health, including emerging diseases such as COVID-19, when funding is available.

Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)

United States · US

Who can apply Private institutions of higher education · Public and State controlled institutions of higher education

The SuRE program supports research capacity building at eligible higher education institutions through funding investigator-initiated biomedical research inbasic, social, clinical, behavioral, or translational science that falls in the mission areas of the NIH. The purpose of SuRE-First awards is to provide support for investigator-initiated research at resource-limited institutions by full-time faculty who have not had any prior independent, peer-reviewed, external research grants, to furnish students with high-quality undergraduate and/or graduate research experiences, and to enhance the institutional scientific research culture.

Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)

United States · US

Who can apply Public and State controlled institutions of higher education · Private institutions of higher education

The SuRE program supports research capacity building at eligible higher education institutions by funding investigator-initiated biomedical research inbasic, social, clinical, behavioral, or translational science that falls in the mission areas of the NIH. The purpose of SuRE awards is to provide support for investigator-initiated research at resource-limited institutions by full-time faculty who are not currently funded by any NIH Research Project Grants (RPGs) with the exception of SuRE or SuRE-First awards, to furnish students with high-quality undergraduate and/or graduate research experiences, and to enhance the institutional scientific research culture.

Method to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)

United States · US

Who can apply Special district governments · County governments · Private institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · For profit organizations other than small businesses · Small businesses · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Native American tribal organizations (other than Federally recognized tribal governments) · City or township governments · Independent school districts · Public and State controlled institutions of higher education · Public housing authorities/Indian housing authorities · State governments · Native American tribal governments (Federally recognized)

The National Cancer Institute (NCI) Method to Extend Research in Time (MERIT) (R37) Award provides extended grant support to Early Stage Investigators (ESIs). By providing such an opportunity for longer term support to ESIs, the NCI intends to offer flexibility and opportunity for creativity and innovation and additional time to successfully launch their careers and to become more established before having to submit renewal applications (NOT-CA-18-037). The objective of the NCI's ESI MERIT Award is to allow eligible investigators the opportunity to obtain up to 7 years of support in two segments:

Exploratory Grants in Cancer Control (R21 Clinical Trial Optional)

United States · US

Who can apply Special district governments · Native American tribal governments (Federally recognized) · Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education · Others (see text field entitled "Additional Information on Eligibility" for clarification) · Public housing authorities/Indian housing authorities · Native American tribal organizations (other than Federally recognized tribal governments) · Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education · Small businesses · For profit organizations other than small businesses · County governments · Private institutions of higher education · City or township governments · Independent school districts · State governments · Public and State controlled institutions of higher education

This funding opportunity announcement (FOA) encourages the submission of exploratory/developmental research grant (R21) applications that focus on different aspects of cancer control by modifying behavior, screening, and understanding etiologic factors contributing to the development of cancer, and developing ways to control cancer. The overarching goal is to provide support to promote the early and conceptual stages of research efforts on novel scientific ideas that have the potential to substantially advance population-based cancer research, such as the development of novel techniques, agents, methodologies, models, or applications that could have a major impact on a field of cancer research (epidemiologic, biomedical, behavioral, health care delivery or clinical).

AHRC Curiosity Award: applicant-led mode (Grant)

United Kingdom · National

Who can apply Public Sector · Non-profit · Private Sector

Apply for funding for flexible awards to fund fundamental research that leads to new research agendas, networking activity and idea generation, which enables the development of further research opportunities and new research agendas. You must be based at a UK research organisation eligible for AHRC funding. There is no limit on the value of the grant, the value specified within the summary page is an example.

Period: Sep 23, 2026 – —

AHRC Working with Brazilian researchers: Applicant-led mode (Grant)

United Kingdom · National

Who can apply Public Sector · Non-profit · Private Sector

Apply for funding to work with overseas researchers in the State of São Paulo, Brazil. Submit a collaborative research grant application within the remit of Arts and Humanities Research Council (AHRC) and State of São Paulo Research Foundation (FAPESP). You must be based at a UK research organisation eligible for AHRC funding. There is no limit on the value of the grant, the value specified within the summary page is an example

Period: Sep 23, 2026 – —